These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 31947693)

  • 1. Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs.
    Hadjicharalambous MR; Lindsay MA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?
    Mahendran S; Sethi T
    QJM; 2012 Oct; 105(10):929-34. PubMed ID: 22647761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
    Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
    FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis.
    Huang C; Yang Y; Liu L
    Physiol Genomics; 2015 Oct; 47(10):463-9. PubMed ID: 26269497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis.
    Sun H; Chen J; Qian W; Kang J; Wang J; Jiang L; Qiao L; Chen W; Zhang J
    J Cell Mol Med; 2016 Jul; 20(7):1234-46. PubMed ID: 26824344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation.
    Gokey JJ; Snowball J; Sridharan A; Speth JP; Black KE; Hariri LP; Perl AT; Xu Y; Whitsett JA
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.
    Hewlett JC; Kropski JA; Blackwell TS
    Matrix Biol; 2018 Oct; 71-72():112-127. PubMed ID: 29625182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of non-coding RNA signatures in idiopathic pulmonary fibrosis.
    Elek A; Bozgeyik E; Caska H; Gocer Z; Bozgeyik I
    Ir J Med Sci; 2024 Aug; 193(4):1923-1927. PubMed ID: 38523167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-species integration of single-cell RNA-seq resolved alveolar-epithelial transitional states in idiopathic pulmonary fibrosis.
    Huang KY; Petretto E
    Am J Physiol Lung Cell Mol Physiol; 2021 Sep; 321(3):L491-L506. PubMed ID: 34132117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of long noncoding RNA AP003419.16 predicts high risk of aging‑associated idiopathic pulmonary fibrosis.
    Hao X; Du Y; Qian L; Li D; Liu X
    Mol Med Rep; 2017 Dec; 16(6):8085-8091. PubMed ID: 28944926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications.
    Spagnolo P; Rossi G; Cavazza A
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1005-17. PubMed ID: 24953006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib.
    Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ
    Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices.
    Alsafadi HN; Staab-Weijnitz CA; Lehmann M; Lindner M; Peschel B; Königshoff M; Wagner DE
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L896-L902. PubMed ID: 28314802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis.
    Di Mauro S; Scamporrino A; Fruciano M; Filippello A; Fagone E; Gili E; Scionti F; Purrazzo G; Di Pino A; Scicali R; Di Martino MT; Malaguarnera R; Malatino L; Purrello F; Vancheri C; Piro S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue.
    Newton DA; Lottes RG; Ryan RM; Spyropoulos DD; Baatz JE
    Respir Res; 2021 Oct; 22(1):278. PubMed ID: 34711218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non coding RNA H19: An emerging therapeutic target in fibrosing diseases.
    Li J; Cao LT; Liu HH; Yin XD; Wang J
    Autoimmunity; 2020 Feb; 53(1):1-7. PubMed ID: 31646913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis is associated with tight junction protein alterations.
    Zou J; Li Y; Yu J; Dong L; Husain AN; Shen L; Weber CR
    Biochim Biophys Acta Biomembr; 2020 May; 1862(5):183205. PubMed ID: 32001212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in patients with idiopathic pulmonary fibrosis.
    Takezaki A; Tsukumo SI; Setoguchi Y; Ledford JG; Goto H; Hosomichi K; Uehara H; Nishioka Y; Yasutomo K
    J Exp Med; 2019 Dec; 216(12):2724-2735. PubMed ID: 31601679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
    Roque W; Boni A; Martinez-Manzano J; Romero F
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts.
    Hadjicharalambous MR; Roux BT; Feghali-Bostwick CA; Murray LA; Clarke DL; Lindsay MA
    Front Immunol; 2018; 9():2906. PubMed ID: 30619270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.